Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-14-063559

President and CEO acquired 1,061,354 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Chan Phillip P. President and CEO 2014-10-09 Conversion +1,061,354 1,799,376 D
Derivatives
Chan Phillip P. President and CEO 2014-10-09 Conversion · Series B 10% Convertible Preferred Stock −384.21 0 D
Loading xslF345X03/v392331_4.xml…